Decision of the EEA Joint Committee No 191/2012 of 26 October 2012 amending Annex I (Veterinary and phytosanitary matters) to the EEA Agreement
Date: 2012-10-26
Institutions: EEA Joint Committee
Subjects: European Economic Area, Japan, brucellosis, rabies, research body, revision of an agreement, vaccination, veterinary inspection




L_2013021EN.01003701.xml










24.1.2013   


EN


Official Journal of the European Union


L 21/37








            DECISION OF THE EEA JOINT COMMITTEE
         
No 191/2012
of 26 October 2012
         
amending Annex I (Veterinary and phytosanitary matters) to the EEA Agreement


THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:







(1)


Commission Implementing Regulation (EU) No 176/2012 of 1 March 2012 amending Annexes B, C and D to Council Directive 90/429/EEC as regards animal health requirements for brucellosis and Aujeszky’s disease (1) is to be incorporated into the EEA Agreement.












(2)


Commission Implementing Decision 2011/396/EU of 4 July 2011 authorising a laboratory in Japan to carry out serological tests to monitor the effectiveness of rabies vaccines (2) is to be incorporated into the EEA Agreement.












(3)


This Decision concerns legislation regarding live animals other than fish and aquaculture animals. Legislation concerning these matters shall not apply to Iceland, as specified in paragraph 2 of the Introductory Part of Chapter I of Annex I to the EEA Agreement. This Decision is therefore not to apply to Iceland.












(4)


This Decision concerns legislation regarding veterinary matters. Legislation regarding veterinary matters shall not apply to Liechtenstein as long as the application of the Agreement between the European Community and the Swiss Confederation on trade in agricultural products is extended to Liechtenstein, as specified in the sectoral adaptations to Annex I to the EEA Agreement. This Decision is therefore not to apply to Liechtenstein.












(5)


Annex I to the EEA Agreement should therefore be amended accordingly,





HAS ADOPTED THIS DECISION:



Article 1
Chapter I of Annex I to the EEA Agreement shall be amended as follows:






(1)


the following indent shall be added in point 8 (Council Directive 90/429/EEC) in Part 4.1 and point 7 (Council Directive 90/429/EEC) in Part 8.1:






‘—



32012 R 0176: Commission Implementing Regulation (EU) No 176/2012 of 1 March 2012 (OJ L 61, 2.3.2012, p. 1).’;














(2)


the following point shall be inserted after point 96 (Commission Decision 2011/91/EU) in Part 4.2:






‘97.



32011 D 0396: Commission Implementing Decision 2011/396/EU of 4 July 2011 authorising a laboratory in Japan to carry out serological tests to monitor the effectiveness of rabies vaccines (OJ L 176, 5.7.2011, p. 51).
This act shall not apply to Iceland.’
                                    










Article 2
The texts of Implementing Regulation (EU) No 176/2012 and Implementing Decision 2011/396/EU in the Norwegian language, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.


Article 3
This Decision shall enter into force on 1 November 2012, provided that all the notifications under Article 103(1) of the EEA Agreement have been made to the EEA Joint Committee (*1).


Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.




Done at Brussels, 26 October 2012.


For the EEA Joint Committee


The President

Atle LEIKVOLL
            





(1)  
            OJ L 61, 2.3.2012, p. 1.

(2)  
            OJ L 176, 5.7.2011, p. 51.

(*1)  No constitutional requirements indicated.